BUONTEMPO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1819
EU - Europa 1274
AS - Asia 579
AF - Africa 93
SA - Sud America 5
OC - Oceania 1
Totale 3771
Nazione #
US - Stati Uniti d'America 1816
GB - Regno Unito 415
VN - Vietnam 271
SE - Svezia 254
CN - Cina 216
IT - Italia 194
DE - Germania 162
IN - India 70
RU - Federazione Russa 57
FR - Francia 55
UA - Ucraina 46
TG - Togo 41
ZA - Sudafrica 41
EE - Estonia 35
BE - Belgio 14
IR - Iran 13
AT - Austria 12
NG - Nigeria 6
CL - Cile 5
FI - Finlandia 5
PT - Portogallo 5
RO - Romania 5
LB - Libano 4
CA - Canada 3
NL - Olanda 3
PL - Polonia 3
EG - Egitto 2
ES - Italia 2
GR - Grecia 2
KR - Corea 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IL - Israele 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 3771
Città #
Southend 384
Fairfield 278
Chandler 188
Dong Ket 173
Houston 170
Woodbridge 154
Wilmington 143
Ashburn 139
Seattle 131
Ann Arbor 108
Bologna 101
Cambridge 91
Princeton 84
Lomé 41
Westminster 41
Nanjing 39
Padova 36
Berlin 25
Bremen 24
Jinan 23
Shenyang 21
Jacksonville 19
Saint Petersburg 19
Beijing 17
Changsha 16
Boardman 13
Brussels 13
Falls Church 13
Nanchang 13
Redmond 12
Haikou 10
Hebei 10
Medford 10
Norwalk 10
San Diego 10
Vienna 10
Hangzhou 9
Jiaxing 8
Dearborn 7
Abeokuta 6
Ningbo 6
Tianjin 6
Zhengzhou 6
Fuzhou 5
Helsinki 5
Redwood City 5
Andover 4
Clearwater 4
Kuban 4
Plauen 4
Zanjan 4
Castiglione Delle Stiviere 3
Frankfurt am Main 3
Guangzhou 3
Hefei 3
Kashan 3
Kish 3
Milan 3
Rome 3
San Francisco 3
Trapani 3
Borgoricco 2
Bucharest 2
Cedar Knolls 2
Chicago 2
Chieri 2
Den Haag 2
Ferrara di Monte Baldo 2
Fort Worth 2
Kiev 2
Kunming 2
Lisbon 2
Ludwigshafen 2
Monmouth Junction 2
Moscow 2
San Venanzo 2
Taiyuan 2
Taizhou 2
Toronto 2
Ancona 1
Baotou 1
Bratislava 1
Buffalo 1
Cava De' Tirreni 1
Costa Mesa 1
Des Moines 1
Frankfurt Am Main 1
Fremont 1
Haifa 1
Imola 1
Kwangju 1
Lanzhou 1
Leawood 1
London 1
Madrid 1
Mahé 1
New York 1
North Vancouver 1
Parma 1
Phoenix 1
Totale 2759
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 178
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 157
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 151
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 133
Therapeutic targeting of CK2 in acute and chronic leukemias. 133
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 124
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 122
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 117
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 117
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 115
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 112
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 109
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 103
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 99
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 99
null 95
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 93
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 93
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 92
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 92
Nuclear phosphoinositides and their roles in cell biology and disease. 88
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 88
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 87
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 86
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 85
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 84
null 83
GSK-3β: a key regulator of breast cancer drug resistance 81
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 76
null 75
Drug discovery targeting the mTOR pathway 75
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 71
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 68
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 67
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 65
null 61
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 60
null 52
null 45
null 43
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 41
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 29
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 22
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 10
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 9
Tyrosol prevents apoptosis in irradiated keratinocytes. 7
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 6
HNE protein adducts and apoptosis in osteosarcoma cells 6
Compact and very high dose-rate plasma focus radiation sources for medical applications 5
Totale 3909
Categoria #
all - tutte 5542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201882 0000 00 08 00713
2018/2019274 442513 737 1718 18413042
2019/20201260 17238668 138149 146144 192735381
2020/2021657 122471522 715 1527 612433269
2021/2022969 149196159 8749 1962 37127183117
2022/2023583 8513052146 5969 420 0000
Totale 3909